ALAYNA EMMERLING: Open Payments
NPI 1508380858 · CLINTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 23 payments from 12 companies in 2025. Trend: 2023 $394 · 2024 $483 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $88 |
| Lundbeck LLC | 3 | $57 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
| Azurity Pharmaceuticals, Inc. | 3 | $49 |
| Globus Medical, Inc. | 1 | $45 |
| PFIZER INC. | 2 | $40 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Averitas Pharma Inc. | 1 | $23 |
| Boston Scientific Corporation | 1 | $22 |
Products named: VYEPTI, Belbuca, HORIZANT, Senza, NURTEC ODT, UBRELVY, QULIPTA, JOURNAVX.
Industry payments across UT — which companies pay providers there.
